Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2025-12-24 @ 10:14 PM
NCT ID:
NCT04640935
Eligibility Criteria:
Inclusion Criteria:
* At least 18 years old;
* Histologically or cytologically confirmed diagnosis of non-epidermal NSCLC;
* Advanced stage IV disease at the start of treatment with paclitaxel-bevacizumab according to TNM 7/8th edition classification;
* Treatment with paclitaxel-bevacizumab received as second-line therapy or beyond, in a clinical trial or not;
* Alive patients not opposed to the use of their data
Exclusion Criteria:
* Patient under guardianship or curatorship at the date of the study ;
* Patients alive at the time of the study who are opposed to the use of their data
* Opposition to the use of their data expressed during the lifetime of patients who died at the time of the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04640935
Study Brief:
Protocol Section:
NCT04640935